This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

Rafet Basar
Assistant Professor at MD Anderson Cancer Center, USA


I received my MD degree from Abant Izzet Baysal University in Turkey in 2009 and completed my residency in Internal Medicine at the Istanbul Faculty of Medicine in 2015. Following my clinical training, I began my research training as a post-doctoral research fellow in Stem Cell Transplantation and Cellular Therapy department in the Division of Cancer Medicine under the mentorship of Dr. Katayoun Rezvani to focus on adoptive cellular therapy and cancer immunology. I was recently promoted to the rank of assistant professor in the department of stem cell transplant and cellular therapy at MDACC. Throughout my career at MD Anderson Cancer Center my work has been dedicated to developing innovative methods to enhance the potency of NK cellular therapy products using state of the art genetic engineering strategies for the treatment of hematologic malignancies, engineering cytotoxic T cells to treat post-transplant viral infections and characterizing B cells for the purpose of viable expansion and suppression along with their role in the tumor milieu. I have developed a novel strategy combining chimeric antigen receptor (CAR) engineering with CRISPR Cas9 multiplex gene editing to knock out multiple inhibitory molecules simultaneously such as TGFBRII, CISH and NKG2A, for the generation of highly potent cells for cancer immunotherapy.

Agenda Sessions

  • The Potential of NK Cell Based Therapies for Cancer Treatment


Speakers at this event